Traumatic brain injury (TBI) that occurs in early adulthood is associated with cognitive decline in later life, results from a study of identical twins who served […]

Earlier diagnostic screening, routine and emerging therapies, and increased awareness are helping people with the lysosomal storage disorder Fabry disease lead a longer, healthier life. Because […]

(Reuters) – Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the […]

A national shortage of neurologists is creating “neurology deserts” around the country, forcing patients to wait longer and drive further for care, news that comes as […]

Lecanemab (Lequembi, Esai), an amyloid beta–directed antibody therapy, is approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease (AD). But […]

Only about 1 in 10 older adults with chronic low back pain and comorbid opioid use disorder (OUD) receive guideline-recommended nonpharmacologic pain therapies, with Black and […]

TOPLINE: The disease-modifying treatment (DMT) delays conversion to clinical multiple sclerosis (MS) for patients with radiologically isolated syndrome (RIS) and has a reassuring long-term safety profile, new […]

New research hints at the possibility that cerebral amyloid angiopathy (CAA), a cause of spontaneous brain hemorrhage, can be transmitted via blood transfusion, raising the risk […]

COPENHAGEN — A novel, continuous levodopa/carbidopa (LD/CD) infusion appears to increase treatment on times among patients with Parkinson’s disease and improve clinician- and patient-rated outcomes, suggest […]